Unpad Pharmacy Students Successfully Develop New Methods for Early Detection of Breast Cancer
[unpad.ac.id/21/6/2019] The high incidence and mortality from breast cancer in the world inspires Lutfi Utami Setyawati, Risda Rahmi Islamiaty, and Kevin Reinard Lie to develop more effective methods for early detection of breast cancer.
The three Unpad Faculty of Pharmacy students were guided by Prof. Muchtaridi, Ph.D., Apt., succeeded in developing a new breast cancer early detection method in the Exact Research Student Creativity Program (PKM-PE) funded by the Ministry of Research, Technology and Higher Education in the 2019 budget year.
The research was conducted in collaboration with the National Nuclear Energy Agency (Batan) Bandung, assisted by Wiwit Nurhidayah, S.Si., Maula Eka Sriyani, M.Sc., Rizky Juwita, M.Pharm., Apt., And Eva Maria W., M.Sc.
In the release received by the Unpad Public Communication Office, it was stated that this early detection method uses a mixture of drugs with radioactive materials called radiopharmaceuticals. The compounds used in this method are 99mTc – α-mangostin & 131I – α-mangostin compounds. These compounds are believed to be able to detect and treat breast cancer.
According to Lutfi, in making radiopharmaceutical compounds, it should be noted the success of the making of the radiopharmaceutical. So, a method is needed to analyze the success of making the radiopharmaceutical.
“The method that we developed is a new method that is green material (raw material from plants), faster, cheaper, and effective to determine the success of making radiopharmaceuticals,” Lutfi Utami said.
This group has succeeded in validating the radiopharmaceutical analysis method and satisfying results have been obtained, where the compounds they use are ready for safety testing. *
Release / mar | Translated by dfa